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Abstract
Background—Bisphenol A (BPA) toxicity and exposure risk to humans has been the subject of 
considerable scientific debate; however, published occupational exposure data for BPA are limited.
Methods—In 2013–2014, 77 workers at six US companies making BPA, BPA-based resins, or 
BPA-filled wax provided seven urine samples over two consecutive work days (151 worker-days, 
525 samples). Participant information included industry, job, tasks, personal protective equipment 
used, hygiene behaviors, and canned food/beverage consumption. Total (free plus conjugated) 
BPA, quantified in urine by mass spectrometry, was detected in all samples.
Results—The geometric mean (GM) creatinine-adjusted total BPA (total BPACR) concentration 
was 88.0 μg g−1 (range 0.78–18 900 μg g−1), ~70 times higher than in US adults in 2013–2014 
(1.27 μg g−1). GM total BPACR increased during Day 1 (26.6–127 μg g−1), decreased by pre-shift 
Day 2 (84.4 μg g−1) then increased during Day 2 to 178 μg g−1. By industry, baseline and post-
baseline total BPACR was highest in BPA-filled wax manufacturing/reclaim (GM = 111 μg g−1) 
and lowest in phenolic resin manufacturing (GM = 6.56 μg g−1). By job, total BPACR was highest 
at baseline in maintenance workers (GM = 157 μg g−1) and post-baseline in those working with 
molten BPA-filled wax (GM = 441 μg g−1). Workers in the job of flaking a BPA-based resin had 
the lowest concentrations at baseline (GM = 4.81 μg g−1) and post-baseline (GM = 23.2 μg g−1). In 
multiple regression models, at baseline, industry significantly predicted increased total BPACR (P 
= 0.0248); post-baseline, handling BPA containers (P = 0.0035), taking ≥3 process/bulk samples 
with BPA (P = 0.0002) and wearing a Tyvek® coverall (P = 0.0042) significantly predicted 
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increased total BPACR (after adjusting for total BPACR at baseline, time point, and body mass 
index).
Conclusion—Several work-related factors, including industry, job, and certain tasks performed, 
were associated with increased urinary total BPACR concentrations in this group of manufacturing 
workers. The potential for BPA-related health effects among these workers is unknown.
Keywords
biological monitoring; bisphenol A; determinants of exposure; exposure assessment; occupational 
groups; reproductive health; urine analysis
Introduction
Bisphenol A (BPA) (CAS 80-05-7, 4,4′-isopropylidenediphenol) is used as a monomer in 
the production of polycarbonate, epoxy, and phenolic resins and as a reactant in making 
certain halogenated flame retardants (Kopf, 2003; Mack, 2004; Pham and Marks, 2004; 
Brunelle, 2014); residual BPA in these products is minimal. BPA is also used as a filler in 
certain investment casting waxes (Carney, 2014), where BPA can comprise up to 45% of the 
wax, and as a developer in thermal paper (USEPA, 2014); in both applications, BPA is 
unreacted. At room temperature, BPA is a white solid prill (dry sphere) or flake. BPA 
exposure is widespread in the USA; 92.6% of people ≥6 years of age had BPA detected in 
their urine (Calafat et al., 2008). Diet is thought to be the main non-occupational source of 
BPA exposure (NTP, 2008). BPA-coated thermal paper and certain dental materials are also 
possible BPA sources (Fleisch et al., 2010; Ehrlich et al., 2014).
After ingestion, BPA rapidly undergoes first-pass metabolism in the human liver to form 
water-soluble BPA glucuronide (BPA-G), BPA’s major metabolite, with an elimination half-
life for total BPA in urine of 5.4–6.4 h (Völkel et al., 2002; Thayer et al., 2015). At oral 
doses between 50 and 100 μg kg−1 bw, BPA elimination in humans is essentially complete 
within 24 h (Völkel et al., 2002; Thayer et al., 2015). The metabolism and elimination of 
BPA after inhalation exposure has not been reported, and data are limited after dermal 
exposure. In vitro penetration and absorption of BPA into human or pig skin ranges from 9 
to 13% (Kaddar et al., 2008; Mørck et al., 2010; Demierre et al., 2012), with one report of 
46% in human skin explants (Zalko et al., 2011).
The toxicity of BPA in humans has been the subject of extensive research and considerable 
controversy. Although BPA has low acute toxicity in humans (European Union, 2008), it is 
weakly estrogenic (Dodds and Lawson, 1936), a finding confirmed in numerous in vitro and 
in vivo studies ((NTP, 2008). BPA-G, unlike free BPA, does not exhibit estrogenic activity 
(Snyder et al., 2000; Matthews et al., 2001). BPA exposure has been associated with health 
effects in animal and epidemiological studies with endocrine system disruption hypothesized 
to play a key role (as reviewed in WHO, 2011; Cantonwine et al., 2013; Rochester, 2013; 
Lakind et al., 2014; Peretz et al., 2014; Rezg et al., 2014).
Occupational exposure to BPA has been studied largely among manufacturing workers in 
Asia (Hanaoka et al., 2002; Xiao et al., 2005; Cha et al., 2008; He et al., 2009; Ren et al., 
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2012; Wang et al., 2012; Zhuang et al., 2015) and in cashiers (Ndaw et al., 2016; Thayer et 
al., 2016). Because of the scientific debate around BPA and the lack of published data on 
BPA exposure among US manufacturing workers, the National Institute for Occupational 
Safety and Health (NIOSH) conducted a study in 2013–2014 to quantify urinary BPA in US 
workers engaged in making BPA or products made with BPA. BPA air and hand wipe data 
will be reported separately.
Methods
Company and participant recruitment
Seventy-three companies potentially making or using BPA were identified from the 2010 (n 
= 66) and 2011 (n = 2) US Environmental Protection Agency (EPA) Toxic Release Inventory 
(USEPA, 2016a) and by referral (n = 5). Among the 73 companies, 15 did not respond; 15 
no longer produced or used BPA; 37 either had few workers handling BPA, infrequent BPA 
use, or could not be scheduled within the study period; and 6 participated in the study. We 
visited participating companies to identify BPA-related jobs and invited workers performing 
these jobs to participate in the study. This study was approved by the NIOSH Institutional 
Review Board. Participants gave written informed consent and were reimbursed $70 for the 
time and inconvenience of providing samples.
Sample collection
Participants were sampled over two consecutive work days after having been scheduled to be 
off work for at least 24 h. On Day 1, participants collected pre-shift, mid-shift (±30 min of 
participant’s shift mid-point), endshift, and post-shift (4–6 h after leaving work) urine 
samples. On Day 2, participants collected pre-shift, mid shift, and end-shift samples for a 
total of seven samples (Time Points 1–7). To collect samples, participants were given an 
insulated bag containing a sterile, 120-ml polypropylene specimen cup (Samco™) in a 
‘BPA-free’ Ziploc ® or Glad® plastic bag, a large Kimwipe™ towel (Kimtech Science) pre-
screened to be BPA-free, and frozen refrigerant packs for post-shift samples. Participants 
were instructed to wash hands with water only (to avoid potential interferences), dry hands 
with the provided towel, place the cup cap in the plastic bag to prevent contamination, 
collect the urine, write the void date and time on the cup label, and place the sample in the 
plastic bag.
For sample processing, study staff donned nitrile gloves (Kimberly-Clark), swirled the cup 
to mix the urine, measured specific gravity (SG) using a handheld refractometer (Atago® 
USA, Inc.) calibrated with distilled water, and aliquoted the urine into 5-ml Nalgene® 
polypropylene cryovials (ThermoFisher Scientific, Inc.) using sterile 5.8-ml Fisherbrand™ 
polyethylene transfer pipets (ThermoFisher Scientific, Inc.).
Quality control (QC) field blanks (FB) (two types) and blind duplicates of participant 
samples were collected. For the first FB (FB1), study staff took a kit to the bathroom used by 
participants, followed collection instructions and filled the specimen cup with 60 ml of 
Optima® LC/MS water (ThermoFisher Scientific, Inc.). For the second FB (FB2), the cup 
was filled with 60 ml of Optima® LC/MS water where samples were processed. FB and 
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duplicate samples were aliquoted as described above. Cryovials were placed and shipped on 
dry ice, then stored at −80°C. The laboratory was blind to all participant information. The 
mean (±SD) duration from sample void time to freeze time was 2.5 ± 3.6 h (range 0.07–18 
h), within the stability period for BPA-G in urine at room temperature (Waechter et al., 
2007; Ye et al., 2007).
Sample analysis
We quantified urinary concentrations of free and total (free plus conjugated) BPA by online 
solid phase extraction-high performance liquid chromatography-isotope dilution tandem 
mass spectrometry (Zhou et al., 2014). Each analytical run included calibration standards, 
reagent blanks, and high and low concentration QC urine materials. The limit of detection 
(LOD) was 0.1 μg l−1. The mean (±SD) relative difference in the blind duplicates (n = 26) 
was 6.7 ± 4.7% (total BPA) and 5.9 ± 6.7% (free BPA). The mean (±SD) coefficient of 
variation (CV) for total BPA in QC materials (n = 83 each) was 6.4 ± 2.1% (QC low) and 3.7 
± 0.9% (QC high). For FB1 (n = 17), we detected total and free BPA in one (but different) 
blank each; for FB2 (n = 26), we detected total BPA in two blanks. Blank concentrations 
were at or near the LOD; therefore, we did not FB-correct BPA concentrations. Urine 
samples were analyzed within 1–5 months of collection, within BPA-G’s stability period 
when frozen (Ye et al., 2007).
We measured urinary creatinine using a Vitros® 250 Chemistry Analyzer (Ortho-Clinical 
Diagnostics). Each run included calibration standards and high and low concentration pooled 
urine QC. The lower reportable limit was 1.7 mg dl−1. The mean (±SD) relative difference 
for blind splits was 4.2 ± 7.0% (n = 26). The mean (±SD) CV across five runs was 2.7 
± 1.7% (QC low) and 3.2 ± 2.2% (QC high). To adjust for urine dilution, BPA 
concentrations were divided by creatinine (units = μg g−1 creatinine) or multiplied by (1.024 
− 1)/(SG − 1) (units = μg l−1) (Elkins et al., 1974).
Other information collected
For each participant, we collected information on sex, age, race/ethnicity, self-reported 
weight and height, job, shift duration, current smoking (yes/no), hours since last worked, and 
jobs worked during days off. We asked participants about the number of canned beverages 
and canned foods consumed in the past 24 h, dental procedures in the past 3 days (Day 1) 
and past 24 h (Day 2), clothing and personal protective equipment worn during work, BPA-
related tasks performed, hand washing frequency during work, BPA spills, hand-to-mouth 
behaviors during work, changing clothes at shift end, and showering/bathing between Day 1 
and Day 2.
We grouped companies into five industry categories: (i) phenolic resin manufacturing 
(Companies 1 and 2), (ii) BPA and polycarbonate manufacturing (Company 3), (iii) BPA-
filled wax manufacturing/reclaim (Company 4), (iv) BPA manufacturing (Company 5), and 
(v) BPA-filled wax manufacturing/investment casting (Company 6). We assigned each 
worker’s job into one of seven job categories: (i) making BPA, (ii) kettle/reaction/field 
operator making a BPA-based resin (hereafter referred to as ‘kettle operator’), (iii) operator 
flaking a BPA-based resin, (iv) maintenance work in a BPA or resin manufacturing area, (v) 
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making BPA-filled wax, (vi) working with solid BPA-filled wax (e.g. wax injection, pattern 
and mold assembly), and (viii) working with molten BPA-filled wax (e.g. wax reclaim, melt/
burnout of BPA-filled wax from shells/molds). While we attempted to create job categories 
having similar tasks, some task variation occurred within jobs, usually because we did not 
have sufficient sample size to create a separate job(s).
Statistical analysis
We detected total BPA in all urine samples; free BPA in 71% of them. We assigned LOD/2 
to free-BPA concentrations <LOD (Hornung and Reed, 1990). We used the ratio of free to 
total BPA to indicate possible exogenous BPA contamination. We excluded one participant 
from analyses who had two samples with >20% free BPA, a percentage used previously to 
suggest BPA contamination (Guidry et al., 2015; Thayer et al., 2016).
BPA concentrations were skewed to the right; therefore, a natural log transformation was 
applied. We computed summary statistics for total and free BPA, and for the ratio of free to 
total BPA. We split the data into two groups, baseline (Time Point 1) and post-baseline 
(Time Points 2–7). For both groups, we compared geometric means (GM) of creatinine-
adjusted total BPA (total BPACR) by industry and by job using the PROC MIXED procedure 
in SAS; for post-baseline samples, we used a first-order autoregressive covariance structure 
[AR(1)]. We used Tukey’s method to adjust P-values for multiple comparisons.
We conducted separate linear regression modeling for baseline and post-baseline samples 
using the natural log of total BPACR [ln(total BPACR)] as the dependent variable. For the 
baseline analysis, we initially examined one-at-a-time the effect of age, body mass index 
(BMI), total hours off work before collecting the first sample, number of canned beverages 
and canned foods consumed in the past 24 h (separately and combined), current smoking, 
job, and industry on ln(total BPACR). Covariates with a P-value ≤ 0.2 were evaluated in a 
multiple linear regression model.
For the post-baseline analysis, we evaluated 22 covariates as potential predictors of total 
BPACR. These covariates included job, industry, personal protective equipment and clothing 
worn (four covariates), hygiene behaviors (six covariates), work tasks (seven covariates), 
age, number of hours away from work before collecting the first sample, and current 
smoking. Where covariate responses could vary between Day 1 and Day 2, responses for 
Day 1 were assigned to Time Points 2–5 and responses for Day 2 to Time Points 6 and 7. We 
initially examined each covariate one-at-a-time after adjusting for time point, ln(total 
BPACR) at baseline, and BMI. Covariates with a P-value ≤ 0.2 were included in a stepwise 
forward selection regression model with worker treated as a random effect, covariates as 
fixed effects and an AR(1) covariance structure. Covariates were entered into the model until 
all remaining covariates had P-values > 0.05.
In separate linear regression models, we examined the effect of BMI on ln(total BPACR) at 
Time Points 2–7 (separately) after adjusting for age and ln(total BPACR) at baseline. To test 
for a difference in total BPACR between Day 1 and Day 2, we used each person’s averages 
of ln(total BPACR) at Time Points 2 and 3 and 6 and 7 in a mixed model with person as a 
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random effect. These four time points were selected to obtain comparable data between the 2 
days.
Baseline and post-baseline regression models were rerun with ln(creatinine) as an 
independent variable instead of correcting BPA concentrations for creatinine in the 
dependent variable. Statistical analyses were performed in SAS v. 9.3 (SAS Institute, Inc.). 
Significance testing was done at α = 0.05.
Results
Participants
Of 199 eligible workers at six companies (average 33 workers/company, range 25–55), 125 
consented to participate (average consent rate of 63%, range 51–75%/company). We were 
able to schedule 78 (62%) of consenting workers for sampling; 77 remained after excluding 
one participant with possible BPA sample contamination. Two days of sampling were 
completed for 74 workers and 1 day for 3 workers for a total of 151 worker-days. All but one 
of the 77 workers were male, and 89.6% were white (Table 1). Median age was 44 years 
(range 20–63 years). Median BMI was 29.8 kg m−2 (range 21.0–44.3 kg m−2).
Companies
Companies 1 and 2 added BPA and other ingredients to kettles, solidified molten resin, and 
converted it into a flake product. Participant jobs were kettle and flaker operators. Company 
3 made BPA from acetone and phenol, then reacted BPA with phosgene to make 
polycarbonate resin. Participant jobs included operators, shift leads, and maintenance. 
Company 4 added BPA and other ingredients to kettles, then solidified molten wax into 
pastilles, billets, or slabs. Company 4 also reclaimed the wax component from used wax 
using large hot boxes at ~100°C to melt the wax, followed by removal of water and non-wax 
solids. Participant jobs included warehouse, wax preparation, blending and packaging, wax 
reclaim, and QC. Company 5 made BPA from acetone and phenol and then transferred BPA 
to the epoxy resin manufacturing unit via a closed system. Participant jobs included BPA 
operators, flakers, and loaders. Company 6 added BPA and other ingredients to kettles, 
solidified molten wax into pastilles, and used the wax in investment casting. Participant jobs 
included making wax, engineer, shift lead, lift-truck driver, wax injection, wax pattern/mold 
assembly, and wax removal from shells/molds in heated Boilerclaves® at ~170°C followed 
by burnout in ovens at ~1000°C. All companies adding BPA to reaction or mixing kettles 
used a mix of manual/partly manual methods (e.g. emptying bags or bulk sacks into addition 
hoppers) and automated methods (e.g. transporting BPA through enclosed systems). Specific 
addition methods and BPA form (prill or flake) were generally proprietary.
Urinary BPA concentrations
The GM concentration of total BPACR in 525 samples over seven time points was 88.0 μg 
g−1, ~70 times higher than in adults ≥20 years in the 2013–2014 US National Health and 
Nutrition Examination Survey (NHANES) (GM = 1.27 μg g−1) (NHANES, 2016) (Table 2). 
At baseline, the GM total BPACR (26.6 μg g−1) was 20 times higher for adults in NHANES 
2013–2014.
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On average, total BPACR increased from pre-shift to post-shift on Day 1 (pre-shift GM = 
26.6 μg g−1, midshift GM = 60.7 μg g−1, end-shift GM = 115 μg g−1, postshift GM = 127 μg 
g−1), decreased between post-shift Day 1 and pre-shift Day 2 (GM = 84.4 μg g−1) without 
returning to Day 1 pre-shift levels, and then increased during Day 2 (mid-shift GM = 125 μg 
g−1, end-shift GM = 178 μg g−1) (Table 2, Fig. 1). Pre-shift Day 1 GM total BPACR was 
significantly lower than each of the other time points (P < 0.0001 each, Table 2). Differences 
in total BPACR between many other time points were also statistically significant (Table 2). 
Although total BPACR post-shift Day 1 (GM = 127 μg g−1) was higher than end-shift Day 1 
(GM = 115 μg g−1), the difference was not statistically significant. The highest concentration 
measured (18 900 μg g−1) was more than three orders of magnitude higher than the 95th 
percentile of adults from NHANES 2013–2014 (5.09 μg g−1) (NHANES, 2016). We 
averaged total BPACR for Time Points 2–5 for 74 participants with all four samples to obtain 
an approximate ‘24-h’ total BPACR concentration for Day 1 (GM = 96.6 μg g−1, range 3.05–
7890 μg g−1).
Total BPACR by industry and job are presented in Table 3; Figs 2 and 3; and Supplementary 
Figs S1 and S2, available at Annals of Work Exposures and Health online, and by time point 
within industry and job in Supplementary Table S1, available at Annals of Work Exposures 
and Health online. All industries and jobs had GM total BPACR concentrations significantly 
higher than adults in NHANES 2013–2014 (Supplementary Table S2, available at Annals of 
Work Exposures and Health online). By industry, at baseline, total BPACR was highest in 
BPA-filled wax manufacturing/reclaim (GM = 111 μg g−1), followed by BPA/polycarbonate 
manufacturing (GM = 69.4 μg g−1) and BPA manufacturing (GM = 37.4 μg g−1), and lowest 
in phenolic resin manufacturing (GM = 6.56 μg g−1). Compared to phenolic resin 
manufacturing, total BPACR at baseline was significantly higher in BPA-filled wax 
manufacturing/reclaim (P < 0.0001), BPA/polycarbonate manufacturing (P < 0.0001), and 
BPA manufacturing (P = 0.0257). Post-baseline, total BPACR was also highest in BPA-filled 
wax manufacturing/reclaim (GM = 121 μg g−1), followed by BPA/polycarbonate 
manufacturing (GM = 218 μg g−1) and BPA manufacturing (GM = 121 μg g−1), and lowest 
in phenolic resin manufacturing (GM = 33.8 μg g−1). Compared to phenolic resin 
manufacturing, total BPACR post-baseline was significantly higher in BPA-filled wax 
manufacturing/reclaim (P < 0.0001) and BPA/polycarbonate manufacturing (P = 0.0003).
By job, total BPACR at baseline was highest for maintenance (all at Company 3, GM = 157 
μg g−1), followed by working with molten BPA-filled wax (GM = 94.9 μg g−1), and lowest 
for flaking a BPA-based resin (GM = 4.81 μg g−1). Total BPACR at baseline in maintenance 
was 30 times higher than flaking a BPA-based resin (P < 0.0001). Total BPACR post-baseline 
was highest for the job of working with molten BPA-filled wax (GM = 441 μg g−1), 
followed by making BPA-filled wax (GM = 254 μg g−1), and making BPA (GM = 192 μg 
g−1), while lowest for flaking a BPA-based resin (GM = 23.2 μg g−1). Compared to the BPA-
based resin flaking job, total BPACR post-baseline was significantly higher in those working 
with molten BPA-filled wax (P = 0.0027), in those making BPA-filled wax (P = 0.0019), and 
in those making BPA (P = 0.013). The maintenance job showed little difference in total 
BPACR concentrations at baseline (GM = 157 μg g−1) and post-baseline (GM = 156 μg g−1); 
all other jobs showed an increase, although not always significant. Total BPACR in the 
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maintenance job also changed minimally across time points as compared to other jobs 
(Supplementary Table S1, available at Annals of Work Exposures and Health online).
For free BPACR, the GM was 0.43 μg g−1 (range <LOD–62.9 μg g−1, n = 525), with GMs for 
each of the seven time points <1 μg g−1 (Table 2). For percent free BPA, the GM was 0.49 
(75th percentile = 0.9%) (Table 2). SG-adjusted and volume-based (unadjusted) total- and 
free-BPA concentrations are summarized in Supplementary Tables S3 and S4, available at 
Annals of Work Exposures and Health online.
Covariates
Covariate responses are summarized in Tables 1 and 4. Approximately 84% of the 
participants were off work ≥24 h before collecting the first sample; 72% for ≥48 h (range 
11.5–252 h). Twelve participants (15.6%) were off work <24 h due to schedule changes, 7 of 
these worked in maintenance at Company 3. On 133 (88%) out of 151 days, participants 
wore either chemical-resistant gloves (66 days) or fabric/leather gloves (67 days). Respirator 
use was less common, 29 days (19.2%). Tyvek® coveralls were worn on 19 days (12.6%); 
15 of these days at Company 1. Among hand-to-mouth activities queried (Table 4), eating 
during work (excluding lunch and breaks) was most frequent (91 days, 60.3%). Participants 
reported washing their hands during work one to four times on 43 days (28.4%), five to 
seven times on 68 days (45%), and more than seven times on 40 days (26.5%). None of the 
participants had dental work performed or worked at jobs associated with BPA exposure 
during their time off before collecting samples. All but three participants showered/bathed 
between Day 1 and Day 2.
We created several cross-company variables (Table 4). On 80% of the days, participants 
worked >8 h; on 70% of the days participants spent ≥50% of their shift in production areas 
versus control rooms/offices. On 18 days (12%), participants handled one or more containers 
of BPA (bulk sacks, bags, drums, or buckets). On 15 days (9.9%), participants handled one 
or more empty BPA containers. Taking process or bulk samples was dichotomized into less 
than three samples (140 days, 92.7%) or more than three samples (11 days, 7.3%). Because 
of small numbers, we could not examine process sample types separately. Participants 
spilled BPA on 10 days (6.6%) or cleaned up a BPA spill on 12 days (8.0%).
Exposure modeling
In univariate analyses where ln(total BPACR) at baseline was the dependent variable, job (P 
< 0.0001), industry (P < 0.0001), total hours off work before collecting the first sample (P = 
0.0269), and current smoker (P = 0.0813) had P-values ≤ 0.2 (Table 5). When these 
covariates were included in a multiple regression model, only industry remained significant 
(P = 0.0248, data not shown).
We had an a priori interest in the relationship between BMI and total BPACR. After adjusting 
for age and ln(total BPACR) at baseline, we observed significant positive associations 
between BMI and ln(total BPACR) at Time Points 3 (P = 0.0448), 4 (P = 0.0173), 5 (P = 
0.0045), and 7 (P = 0.0075), and borderline significance at Time Point 6 (P = 0.0610) 
(Supplementary Table S5, available at Annals of Work Exposures and Health online). 
Therefore, we adjusted for BMI in post-baseline models.
Hines et al. Page 8
Ann Work Expo Health. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
When ln(total BPACR) post-baseline was the dependent variable, 10 covariates with P-values 
≤ 0.2 in univariate analyses (Table 5) were included in a stepwise forward selection model 
(Table 6). After adjusting for ln(total BPACR) at baseline, time point and BMI, total BPACR 
was positively associated with handling containers of BPA (1.8 times, P = 0.0035), taking 
more than three process/bulk samples (2.33 times, P = 0.0002) and wearing a Tyvek® 
coverall (1.93-times, P = 0.0042). Stepwise results for SG-adjusted total BPA were generally 
similar (Supplementary Table S6, available at Annals of Work Exposures and Health online).
We found a significant 64% increase in total BPACR from Day 1 to Day 2 when comparing 
the average of Time Points 6 and 7 (GM = 152 μg g−1) to the average of Time Points 2 and 3 
(GM = 92.5 μg g−1) (P < 0.0001, n = 72). We did not find a significant interaction between 
day and industry (P = 0.28) or between day and job (P = 0.60), although total BPACR 
increased from Day 1 to Day 2 in all industries (1.3–2.0 times) and jobs (1.2–1.9 times) 
except maintenance (1.0 times) (data not shown).
Regression models that included ln(creatinine) as a covariate gave similar results, including 
coefficients, standard errors, and P-values (Supplementary Tables S7–S9, available at Annals 
of Work Exposures and Health online).
BPA intake estimation
Absent human data on BPA elimination following inhalation or dermal exposures, we 
applied a simplified approach to estimate a participant’s 24-h BPA intake on Day 1 
[equation (1)]. Specifically, we used the average total BPACR concentrations at Time Points 
2–5, the average creatinine concentration at the four times, imputed values for 24-h urine 
volume representing the mean (1.2 l) and range (0.6–2.0 l) for adults (Wallach, 2007), and 
self-reported body weight. The GM (range) estimated BPA intake for Day 1 was 0.88 μg 
kg−1 day (0.035–73.9 μg kg−1 day, n = 74) for a urine volume of 0.6 l, 1.77 μg kg−1 day 
(0.069–148 μg kg−1 day) for 1.2 l, and 2.95 μg kg−1 day (0.12–246 μg kg−1 day) for 2.0 l 
(Supplementary Table S10, available at Annals of Work Exposures and Health online). 
Based on these estimates, 1.4% of the participants at a urine volume of 0.6 l, 2.7% at 1.2 l, 
and 8.1% at 2.0 l exceeded the US EPA oral Reference Dose for BPA of 50 μg kg−1 day 
(USEPA, 2016b). Exceedance fractions were higher when comparing estimates to the 
European Food Safety Authority temporary Tolerable Daily Intake of 4 μg kg−1 day (EFSA, 
2015), 20.3% at a urine volume of 0.6 l; 28.4% at 1.2 l, and 41.6% at 2.0 l. Single-day 
estimates may not represent a worker’s lifetime exposure. Also, different approaches were 
used by EFSA (forward modeling of external exposure), EPA [lowest observable adverse 
effect level], and our study (backward modeling from biomonitoring data) to derive 
reference levels and intake estimates.
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(1)
where bw = body weight.
Discussion
This study is the first broad investigation of BPA exposure among US manufacturing 
workers. GM total BPACR concentrations across seven collection time points were 20–140 
times higher than NHANES 2013–2014 for adults in the USA (NHANES, 2016) suggesting 
that BPA exposure among participants was mostly occupational. The generally increasing 
trend in total BPACR concentrations across 2 days was consistent with workplace exposure. 
Tasks involving BPA such as handling BPA containers or taking process/bulk samples 
containing BPA were positively associated with total BPACR post-baseline. We did not find 
evidence that canned food or canned beverage consumption contributed significantly to total 
BPACR in these workers. Any dietary contribution was likely overshadowed by the 
occupational contribution.
Post-baseline, the highest exposed job was working with molten BPA-filled wax. BPA 
exposure routes for these workers are unclear. While hot boxes used to melt wax for 
reclamation and Boilerclaves® used to melt wax out of shells/molds were closed during 
operation, workers opened hot box and Boilerclave® doors at cycle completion. Reclaim 
workers may have had dermal contact with used wax or with solid non-wax residues; 
however, for Boilerclave® workers, wax patterns were encased in a ceramic shell and 
dermal contact with the wax seemed unlikely. At room temperature, BPA has a low vapor 
pressure (3.96 × 10−7 to 8.7 × 10−10 mm Hg) and a high boiling point (398°C at 760 mm 
Hg) (Staples et al., 1998). Therefore, vapor phase exposure to BPA would not be expected at 
normal temperature and pressure (20°C, 100 kPa). We are not aware of experimental data on 
the potential for vapor formation at temperatures ≥ 100°C. The job that appeared to have the 
most dermal contact with BPA-filled wax, making wax patterns and mold assemblies, had 
the second lowest post-baseline total BPACR concentration, although only four workers 
performed this job. Chemical-resistant glove use did not appear to explain higher BPA 
concentrations in molten wax workers as compared to solid wax workers; chemical-resistant 
gloves were worn more frequently in the molten wax job (nitrile gloves on 6 out of 12 days), 
than in the solid wax job (rubber gloves on 1 out of 8 days). Respirators were not worn on 
any days for either job. The job of flaking a BPA-based resin had the lowest post-baseline 
total BPACR concentration, consistent with BPA having been largely consumed in making 
the resin.
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Reasons for high baseline total BPACR concentrations, even with >70% of the participants 
off work ≥48 h before collecting their first sample are unclear. Possibilities include 
insufficient elimination time for some workers, a longer-than-expected elimination halflife, 
unaccounted for BPA exposure away from work, or BPA storage in the body. In univariate 
analyses, we saw a significant inverse relationship between total BPACR at baseline and total 
hours off work before the baseline sample (Table 5 and Supplementary Fig. S3, available at 
Annals of Work Exposures and Health online), although the effect did not persist in the 
multiple regression model. While no workers reported having a job during their time off 
likely involving BPA exposure, we cannot rule out off-job exposure from take-home BPA 
residues on clothes, in vehicles or in homes.
Workers in our study were most likely exposed repeatedly to BPA via inhalation or dermal 
contact over months or years whereas elimination half-life estimates in humans are based on 
single oral doses. Teeguarden et al. (2015) found no evidence of a BPA depot in humans 
after ingesting a single dose of BPA; however, in an analysis of >1400 NHANES 2003–2004 
participants, urinary BPA concentrations did not decline rapidly with fasting time and the 
estimated ‘population’ half-life was 43 h (Stahlhut et al., 2009). Our results, Stahlhut et al. 
(2009), and those of another fasting study (Christensen et al., 2012) raise the question of 
whether unaccounted for sources of BPA or accumulation and slow release of BPA from 
tissues, including after dermal exposure, could influence urinary BPA concentrations. BPA is 
moderately lipophilic (Staples et al., 1998). In in vitro studies, human adipose tissue had the 
highest BPA concentration (Csanády et al., 2002; Geens et al., 2012). Thus, BPA storage in 
fat under certain conditions may be biologically plausible.
The positive association of wearing a Tyvek® coverall with total BPACR was unexpected for 
an item intended to prevent dermal exposure. Wearing Tyvek® may represent some 
unmeasured aspect of handling BPA, e.g. on 12 out 19 days that Tyvek® was worn 
participants handled sacks, bags, or buckets of BPA or worked closely with someone who 
performed these tasks. Or perhaps when removing Tyvek®, workers were exposed to 
resuspended BPA in the air or had skin contact with BPA residues on the garment.
The He et al. (2009) study of workers in BPA and epoxy resin manufacturing plants in China 
is most comparable to our study. Pre-shift total BPACR concentrations in the Chinese 
workers (median = 84.6 μg g−1) and in our US workers (Day 1 pre-shift GM = 26.6 μg g−1) 
were higher than NHANES 2013–2014 participants (GM = 1.27 μg g−1) indicating that total 
BPACR had not dropped to background levels before re-exposure at work. He et al. (2009) 
did not report the timing of sample collection in relation to time off work. Our Day 2 
preshift concentrations (GM = 84.4 μg g−1) were similar to He et al. (2009) at pre-shift. 
Compared to end-shift concentrations in the Chinese workers (median = 111 μg g−1), our 
Day 1 end-shift concentrations were similar (GM = 115 μg g−1), but our Day 2 
concentrations (GM = 178 μg g−1) were 60% higher. In a cross-sectional study of these 
BPA-exposed male Chinese workers, changes in self-reported sexual dysfunction, 
reproductive hormone levels, and semen quality were reported (Li et al., 2010a, 2010b, 
2011; Zhou et al., 2013; Liu et al., 2015). GM total BPACR concentrations for workers in our 
study were comparable to (pre-shift and end-shift Day 1) or higher than (end-shift Day 2) 
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concentrations reported for the Chinese workers. Endpoints in the Chinese study have not 
been evaluated in another similarlyexposed occupational group.
A few other studies have been conducted among BPA-exposed workers. Cashiers handling 
BPA-coated thermal paper receipts in the USA had pre-shift total BPACR concentrations 14 
times lower than in our study and end-shift concentrations 42 times (Day 1) and 64 times 
(Day 2) lower than we found (Thayer et al., 2016), while cashiers in France (Ndaw et al., 
2016) had overall total BPACR concentrations more than 10 times lower than in our study. 
Two small studies of Chinese workers making and packaging BPA-based epoxy resins (Ren 
et al., 2012; Wang et al., 2012) generally reported total BPACR concentrations several times 
lower than we found. Total BPACR concentrations in epoxy resin painters were also much 
lower than in our study, consistent with little unreacted BPA remaining in paint (Hanaoka et 
al., 2002; Cha et al., 2008).
Occupational exposure limits have not been established for BPA in urine. Germany has a 
biological guidance value (BGV) of 80 000 μg l−1 for urinary total BPA based on the 
German maximum workplace BPA air concentration of 5 mg m−3, inhalable fraction (DFG, 
2013). Our median concentration (108 μg l−1) was 0.14% of this guidance value, 25th 
percentile (25.4 μg l−1) 0.03%, 75th percentile (379 μg l−1) 0.47%, and maximum (32 900 
μg l−1) 41% (Supplementary Table S3, available at Annals of Work Exposures and Health 
online). The Scientific Committee on Occupational Exposure Limits of the European 
Commission has recommended a BGV intended to identify occupational from non-
occupational exposure of 7 μg l−1 for total urinary BPA based on the 95th percentile for total 
BPA in German adults 20–29 years of age (EC, 2014). In our study, total BPA exceeded 7 μg 
l−1 in 92% of 525 samples (range 1.1–32 900 μg l−1).
Study strengths include a variety of BPA-related jobs and industries, multiple samples per 
worker to capture BPA elimination over time, worker-specific information on possible 
exposure determinants, and information on number of hours off work and canned food/
beverage consumption prior to baseline sampling. The overall low free-BPA percentage 
indicated that urine biomonitoring for BPA can be conducted reliably in workplaces 
handling raw BPA.
Some limitations should also be noted. Although study companies included major producers 
and users of BPA, the companies may not represent all BPA producers/users. Worker 
participation was voluntary, so we may not have captured the full distribution of BPA 
exposures for jobs at each company. Sample size may have limited our ability to identify 
some exposure determinants and the exposure determinants we identified reflected tasks and 
conditions on the days we sampled. Because biomonitoring captures exposure by all routes, 
we could not determine the relative importance of each route from these data alone. Finally, 
our BPA 24-h intake estimates were compared to reference intakes based on elimination 
assumptions following oral exposure, assumptions that may not apply to inhalation or 
dermal exposure.
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Conclusion
US workers manufacturing BPA or making products with BPA had urinary total BPACR 
concentrations averaging ~70 times higher than US adults in NHANES 2013–2014. Total 
BPACR concentrations in the US manufacturing workers were also 10–60 times higher than 
in cashiers handling BPA-coated thermal paper. Determinants of increased BPA exposure 
included total BPACR concentration at baseline, collection time point, BMI, handling 
containers of raw BPA, and taking more than three process samples containing BPA. Total 
BPACR concentrations were especially elevated among workers in jobs/industries handling 
molten BPA-filled wax, a group not previously studied. Because reproductive health effects 
were reported in a cross-sectional study of manufacturing workers in China who had, on 
average, to urinary total BPACR concentrations similar to or above concentrations in our 
study, additional investigation among US workers is warranted.
Supplementary Material
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Figure 1. 
Plot of total BPA (μg g−1) by urine collection time point (Day 1 pre-shift, mid-shift, end-
shift, and post-shift; Day 2 preshift, mid-shift, and end-shift). The box represents the 
interquartile range, and the diamond represents the GM. The solid horizontal line is the GM 
(1.27 μg g−1), and the dashed horizontal line is the 95th percentile (5.09 μg g−1) for total 
BPA from NHANES 2013–2014, adults 20 years and older. N = 525 samples on 151 worker-
days (77 workers).
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Figure 2. 
Box plots of total BPA (μg g−1) by industry for (a) baseline (n = 77) and (b) post-baseline (n 
= 448) samples. The box represents the interquartile range, and the diamond represents the 
GM. Solid horizontal line is the GM (1.27 μg g−1); dashed horizontal line is the 95th 
percentile (5.09 μg g−1) for total BPA from NHANES 2013–2014, adults 20 years and older. 
PC, polycarbonate.
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Figure 3. 
Box plots of total BPA (μg g−1) by job for (a) baseline (n = 77) and (b) post-baseline (n = 
448) samples. The box represents the interquartile range, and the diamond represents the 
GM. Solid horizontal line is the GM (1.27 μg g−1); dashed horizontal line is the 95th 
percentile (5.09 μg g−1) for total BPA from NHANES 2013–2014, adults 20 years and older. 
Mfg, manufacturing; Op., operator.
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Table 1
Characteristics of study participants, N = 77.
Characteristic Frequency (%)
Sex
 Male 76 (98.7)
 Female 1 (1.3)
Age, years AM ± SD = 43.5 ± 11.0; median = 44.0; range = 20–63
Race
 White 69 (89.6)
 Black 6 (7.8)
 More than one race 2 (2.6)
Ethnicity
 Hispanic 2 (2.6)
 Not Hispanic 75 (97.4)
BMI, kg m−2 AM ± SD = 30.4 ± 5.6; median = 29.8; range = 21.0–44.3
Current smoker
 No 52 (67.5)
 Yes 25 (32.5)
Shift type
 Fixed 45 (58.4)
 Rotating 32 (41.6)
Company
 1 (phenolic resin mfg) 15 (19.5)
 2 (phenolic resin mfg) 13 (16.9)
 3 (BPA and PC resin mfg) 18 (23.4)
 4 (BPA-filled wax mfg and wax reclaim) 14 (18.2)
 5 (BPA mfg) 7 (9.1)
 6 (BPA-filled wax mfg, casting patterns/molds, wax burnout) 10 (13.0)
Industry
 Phenolic resin mfg (Companies 1 and 2) 28 (36.4)
 BPA and PC resin mfg (Company 3) 18 (23.4)
 BPA-filled wax mfg and wax reclaim (Company 4) 14 (18.2)
 BPA mfg (Company 5) 7 (9.1)
 BPA-filled wax mfg, casting patterns/molds, wax melt/burnout (Company 6) 10 (13.0)
Job
 Flaker operator—resins 12 (15.6)
 Make/load BPA 12 (15.6)
 Kettle operator—resin mfg (phenolic or PC) 22 (28.6)
 Maintenance—BPA and PC resin mfg 7 (9.1)
 Molten BPA-filled wax work—reclaim, melt/burnout 6 (7.8)
 Make BPA-filled wax 14 (18.2)
 Solid BPA-filled wax work: wax patterns, mold assembly, lab QC 4 (5.2)
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Characteristic Frequency (%)
Total hours off work before collecting first urine sample AM ± SD = 69.6 ± 44.7; median = 62.5; range = 11.5–252
 <24 12 (15.6)
 24 to <48 10 (13.0)
 48 to <72 24 (31.2)
 72 to <96 13 (16.9)
 96+ 18 (23.4)
24 h prior to first urine sample, number of canned:
 Beverages AM ± SD = 1.2 ± 1.8; median = 0; range = 0–8
 Food AM ± SD = 0.29 ± 0.58; median = 0; range = 0–3
 Beverages and food
  None 31 (40.3)
  1–2 cans 28 (36.4)
  >2 cans 18 (23.4)
AM, arithmetic mean; mfg, manufacturing; PC, polycarbonate.
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Table 4
Work-related covariates. N = 77 workers, 151 worker-days, 448 urine samples.
Covariate Category i worker-days n samples
PPE/clothing
 Wore gloves No 18 54
Fabric or leather 67 202
Chemical resistant 66 192
 Wore a respirator No 122 358
Yes 29 90
 Wore a Tyvek® coverall No 132 394
Yes 19 54
 Type of shirt worn Long sleeve 106 317
Short sleeve 45 131
Hygiene
 Smoked during work shift No 129 382
Yes 22 66
 Ate food during work shift No 60 180
Yes 91 268
 Chewed gum during work shift No 120 351
Yes 31 97
 Chewed tobacco during work shift No 124 368
Yes 27 80
 Number of times washed hands during work shift 1–4 43 119
5–7 68 207
>7 40 122
 Changed clothes/uniform before leaving work No 68 203
Yes 83 245
Work activities
 Actual shift length worked, ha ≤8 30 81
>8 and <12 43 132
≥12 78 235
 Percent of shift in production areas (versus offices/control rooms)b <50 45 130
≥50 105 318
 Handled bulk sacks, bags, drums, or buckets of BPA No 133 394
Yes 18 54
 Handled empty bulk sacks, bags, or drum liners of BPA No 136 402
Yes 15 46
 Number of process/bulk samples taken containing BPAc ≤3 140 418
>3 11 30
 Spilled BPA No 141 420
Yes 10 28
 Cleaned up a spill of BPA No 139 412
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Covariate Category i worker-days n samples
Yes 12 36
a
Treated as ordinal in regression models.
bCompanies 1, 2, 3, and 5 had control rooms for monitoring operations.
c
Includes samples of BPA reaction mixtures from kettles, raw BPA, or BPA-based product.
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Table 5
Results of univariate linear regression models for creatinine-adjusted total BPA (μg g−1) at baseline (n = 77) 
and post-baseline (n = 448).
Model β (SE) P-value
Baseline: Dependent variable: ln(total BPACR) at Time Point 1, n = 77a
 Industry <0.0001
  Phenolic resin mfg Ref.
  BPA and PC resin mfg 2.359 (0.408) <0.0001
  BPA-filled wax mfg/reclaim 2.826 (0.442) <0.0001
  BPA mfg 1.740 (0.570) 0.0032
  BPA-filled wax mfg, casting patterns/molds, wax melt/burnout 1.352 (0.497) 0.0082
 Job <0.0001
  Flaker operator—resins Ref.
  Make/load BPA 2.324 (0.565) 0.0001
  Kettle Operator—resin mfg 0.855 (0.497) 0.0895
  Maintenance—BPA and PC resin mfg 3.487 (0.658) <0.0001
  Molten BPA-filled wax work: reclaim, melt/burnout 2.983 (0.692) <0.0001
  Make BPA-filled wax 2.572 (0.544) <0.0001
  Solid BPA-filled wax work: wax patterns, mold assembly, lab QC 1.658 (0.799) 0.0416
 Total hours off work before collecting first urine sample −0.00986 (0.00437) 0.0269
 Current smoker (yes/no = Ref.) 0.741 (0.419) 0.0813
 
b
 BMI, kg m−2 −0.0439 (0.0355) 0.2207
 Number of canned foods consumed past 24 h 0.304 (0.345) 0.3818
 Age, years −0.00466 (0.0184) 0.8009
 Number of cans (food or beverage) consumed past 24 h 0.8876
  None Ref.
  1–2 0.197 (0.461) 0.6698
  >2 0.206 (0.524) 0.6957
 Number of canned beverages consumed past 24 h 0.0119 (0.113) 0.9165
Post-baseline: Dependent variable: ln(total BPACR) at Time Points 2–7, n = 448
 Handled bulk sacks, bags, drums, or buckets of BPA (yes/no = Ref.) 0.935 (0.180) <0.0001
 Wore a Tyvek® coverall (yes/no = Ref.) 1.044 (0.205) <0.0001
 Wore a respirator (yes/no = Ref.) 0.710 (0.158) <0.0001
 Handled empty bulk sacks, bags or drum liners of BPA (yes/no = Ref.) 0.781 (0.179) <0.0001
 Number of process/bulk samples taken containing BPA (>3, ≤ 3 = Ref.) 0.988 (0.233) <0.0001
 Actual shift length worked (treated as ordinal), h 0.285 (0.985) 0.0040
 Glove worn 0.0119
  None Ref.
  Leather or fabric 0.0472 (0.258) 0.8553
  Chemical resistant 0.517 (0.259) 0.0470
 Job 0.0419
  Flaker operator—resins Ref.
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Model β (SE) P-value
  Make/load BPA −0.133 (0.454) 0.7706
  Kettle operator—resin mfg 0.172 (0.368) 0.6418
  Maintenance—BPA and PC resin mfg −1.230 (0.548) 0.0277
  Molten BPA-filled wax work: reclaim, melt/burnout 0.273 (0.554) 0.6171
  Make BPA-filled wax 0.143 (0.435) 0.7433
  Solid BPA-filled wax work; wax patterns, mold assembly, lab QC −0.678 (0.573) 0.2403
 Percent of shift in production areas versus offices/control rooms (≥50%, <50% = Ref.) 0.360 (0.194) 0.0644
 Total hours off work before collecting first urine sample 0.00361 (0.00269) 0.1838
 Age, years −0.0132 (0.0104) 0.2097
 Number of times washed hands during work shift 0.2597
  1–4 Ref.
  5–7 −0.102 (0.149) 0.4952
  >7 0.151 (0.194) 0.4359
 Smoked during work shift (yes/no = Ref.) 0.263 (0.253) 0.2987
 Current smoker (yes/no = Ref.) 0.246 (0.249) 0.3260
 Industry 0.3962
  Phenolic resin mfg Ref.
  BPA and PC resin mfg −0.0646 (0.376) 0.8642
  BPA-filled wax mfg/reclaim 0.586 (0.409) 0.1560
  BPA mfg 0.00451 (0.449) 0.9920
  BPA-filled wax mfg, casting patterns/molds, wax melt/burnout −0.153 (0.387) 0.6937
 Spilled BPA (yes/no = Ref.) 0.164 (0.244) 0.5008
 Changed clothes/uniform before leaving work (yes/no = Ref.) 0.128 (0.202) 0.5259
 Chewed tobacco during work shift (yes/no = Ref.) 0.0929 (0.298) 0.7561
 Chewed gum during work shift (yes/no = Ref.) 0.0608 (0.189) 0.7477
 Type of shirt (short/long = Ref.) 0.0432 (0.217) 0.8426
 Cleaned up a BPA spill (yes/no = Ref.) −0.0106 (0.239) 0.9645
 Ate food during work shift (yes/no = Ref.) −0.000265 (0.137) 0.9985
BMI, body mass index; Mfg, manufacturing; PC, polycarbonate; QC, quality control; Ref., referent group.
aWhen covariates with a univariate P-value ≤ 0.2 (current smoker, hours off, job, and industry) were included in a model, only industry remained 
significant, P = 0.0248.
bWhen BMI adjusted for age, P = 0.2243.
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Table 6
Results of stepwise forward selection regression model for creatinine-adjusted total BPA (μg g−1) at Time 
Points 2–7. n = 448 samples (151 worker-days, 77 workers).
Dependent variable: ln(total BPACR)a B (SE) P-value Factorb
Intercept −0.718 (0.681) 0.2952
ln(total BPACR) at Time Point 1 (baseline) 0.852 (0.0634) <0.0001 2.34c
Time point <0.0001
 2 (mid-shift Day 1) Ref.
 3 (end-shift Day 1) 0.637 (0.0707) <0.0001 1.89d
 4 (post-shift Day 1) 0.664 (0.0972) <0.0001 1.94
 5 (pre-shift Day 2) 0.256 (0.115) 0.0262 1.29
 6 (mid-shift Day 2) 0.598 (0.128) <0.0001 1.82
 7 (end-shift Day 2) 0.917 (0.139) <0.0001 2.50
BMI, kg m−2 0.0603 (0.0198) 0.0032 1.06
Handled bulk sacks, bags, drums, or buckets of BPA
 No Ref.
 Yes 0.590 (0.201) 0.0035 1.80e
Number of process/bulk samples taken containing BPA
 ≤3 Ref.
 >3 0.847 (0.226) 0.0002 2.33
Wore a Tyvek® coverall
 No Ref.
 Yes 0.659 (0.229) 0.0042 1.93
Ref., referent group.
a
Mixed model with a first-order autoregressive covariance structure. Results adjusted for ln(total BPACR) at Time Point 1 (baseline), time point, 
and BMI. Remaining covariates presented in order of entry into the model. Estimated lag-one autocorrelation coefficient (rho) = 0.8499.
b
eβ.
cA 2.34 times increase in total BPACR when total BPACR at Time Point 1 (baseline) increases by a factor of e.
d
Total BPACR is increased 1.89 times at Time Point 3 (end-shift Day 1) as compared to Time Point 2 (mid-shift Day 1). Time Points 4, 5, 6, and 7 
are also compared to Time Point 2.
e
Participants who reported ‘Yes’ had a 1.8 times increase in total BPACR as compared to those who reported ‘No’.
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